Skip to main content
Year archive

IMMUTEP LIMITED — 2020 filings

All 111 regulatory filings released by IMMUTEP LIMITED (IMM) in 2020, sourced directly from the official regulator.

111 Filings
2020 Period
2020 filings (111)
Filing Released Lang
Change in substantial holding 6 pages 2.0MB
Major Shareholding Notification
2020-12-30 English
Appendix 2A 16 pages 262.2KB
Regulatory Filings
2020-12-30 English
Immutep granted US patent for eftilagimod alpha with a PD-1 2 pages 237.1KB
Regulatory Filings
2020-12-29 English
Change in substantial holding 8 pages 1.7MB
Major Shareholding Notification
2020-12-29 English
Change in substantial holding 8 pages 1.7MB
Major Shareholding Notification
2020-12-28 English
Becoming a substantial holder 9 pages 1.7MB
Major Shareholding Notification
2020-12-23 English
Appendix 2A 16 pages 239.2KB
Capital/Financing Update
2020-12-23 English
Change of Director's Interest Notice - Dr Howard 3 pages 150.6KB
Director's Dealing
2020-12-23 English
Change in substantial holding 6 pages 2.0MB
Major Shareholding Notification
2020-12-17 English
Change in substantial holding 6 pages 1.1MB
Major Shareholding Notification
2020-12-16 English
Change in substantial holding 6 pages 2.0MB
Major Shareholding Notification
2020-12-15 English
Immutep Upscales Efti Manufacturing 2 pages 271.5KB
Regulatory Filings
2020-12-15 English
Change in substantial holding 6 pages 2.0MB
Major Shareholding Notification
2020-12-14 English
Ceasing to be a substantial holder 1 page 404.9KB
Major Shareholding Notification
2020-12-14 English
Operational Update 2 pages 254.9KB
Capital/Financing Update
2020-12-14 English
Webcast slides for AIPAC Phase IIb breast cancer trial 25 pages 2.1MB
Investor Presentation
2020-12-10 English
Appendix 2A 16 pages 262.3KB
Capital/Financing Update
2020-12-10 English
Overall Survival data from ph IIb AIPAC breast cancer trial 4 pages 392.6KB
Investor Presentation
2020-12-09 English
Immutep's partner EOC pharma to start Ph II trial in MBC 2 pages 279.9KB
Regulatory Filings
2020-12-09 English
Change in substantial holding 6 pages 1.1MB
Major Shareholding Notification
2020-11-26 English
Cleansing Notice 1 page 190.7KB
Capital/Financing Update
2020-11-24 English
Appendix 2A 16 pages 258.8KB
Capital/Financing Update
2020-11-23 English
Immutep expands TACTI-002 Collaboration Trial with MSD 3 pages 242.3KB
Capital/Financing Update
2020-11-18 English
Immutep completes a A$29.6 million placement 3 pages 285.0KB
Capital/Financing Update
2020-11-18 English
Immutep Investor Presentation 52 pages 2.4MB
Investor Presentation
2020-11-18 English
Proposed issue of Securities - IMM 5 pages 28.2KB
Capital/Financing Update
2020-11-18 English
Change in substantial holding 6 pages 2.0MB
Major Shareholding Notification
2020-11-17 English
Pause in Trading 1 page 109.9KB
Regulatory Filings
2020-11-16 English
Trading Halt 2 pages 288.3KB
Capital/Financing Update
2020-11-16 English
Encouraging Phase II TACTI-002 data reported at SITC 2020 5 pages 360.5KB
Capital/Financing Update
2020-11-09 English
Immutep Announces Australian Patent Grant for IMP701 2 pages 208.3KB
Regulatory Filings
2020-11-08 English
Proposed issue of Securities - IMM 5 pages 27.9KB
Capital/Financing Update
2020-11-05 English
Appendix 3G 15 pages 270.4KB
Share Issue/Capital Change
2020-11-05 English
Change of Director's Interest Notice - Grant Chamberlain 3 pages 303.5KB
Director's Dealing
2020-11-05 English
Immutep to present TACTI-002 phase 2 data at SITC 2020 2 pages 286.3KB
Regulatory Filings
2020-11-02 English
Lapse of Unlisted Options 1 page 244.7KB
Regulatory Filings
2020-11-01 English
Immutep enters into a Licence & Collaboration with LabCorp 2 pages 234.4KB
Capital/Financing Update
2020-10-29 English
2020 AGM Presentation 21 pages 1.0MB
AGM Information
2020-10-26 English
Chairman's AGM Address 3 pages 208.7KB
AGM Information
2020-10-26 English
Results of Meeting 2 pages 275.7KB
Declaration of Voting Results & Voting Rights Announcements
2020-10-26 English
COVID-19 phase 2 investigator initiated trial commences 4 pages 287.7KB
Regulatory Filings
2020-10-22 English
Immutep Quarterly Activities Report & Appendix 4C 9 pages 503.2KB
Interim / Quarterly Report
2020-10-21 English
Immutep granted European patent for IMP761 2 pages 224.3KB
Regulatory Filings
2020-10-20 English
Immutep to present AIPAC Overall Survival data at SABCS 2020 2 pages 288.5KB
Regulatory Filings
2020-10-18 English
Change in substantial holding 6 pages 1.1MB
Major Shareholding Notification
2020-10-05 English
Change of Director's Interest Notice - Mr Voigt 3 pages 185.7KB
Director's Dealing
2020-10-04 English
Change of Director's Interest Notice - Mr Meyers 3 pages 198.3KB
Director's Dealing
2020-10-04 English
Change of Director's Interest Notice - Mr Chamberlain 3 pages 190.9KB
Director's Dealing
2020-10-04 English
Appendix 3G 15 pages 271.7KB
Share Issue/Capital Change
2020-10-01 English
Appendix 2A 17 pages 265.7KB
Regulatory Filings
2020-10-01 English
Annual Report filed on Form 20-F with SEC 137 pages 785.7KB
Annual Report
2020-09-27 English
Annual Report to shareholders 87 pages 1.9MB
Annual Report
2020-09-24 English
Appendix 4G & Corporate Governance Statement 35 pages 432.1KB
Governance Information
2020-09-24 English
Notice of Annual General Meeting/Proxy Form 28 pages 1.2MB
AGM Information
2020-09-24 English
Improving results from stage 1 of TACTI-002 ph II trial 4 pages 278.4KB
Regulatory Filings
2020-09-17 English
Immutep reports improving results from INSIGHT-004 trial 3 pages 268.8KB
Regulatory Filings
2020-09-17 English
Change in substantial holding 6 pages 1.1MB
Major Shareholding Notification
2020-09-13 English
2020 AGM & Key Dates 2 pages 255.5KB
AGM Information
2020-09-10 English
IMM & Monash Uni receive funding grant for LAG-3 Research 2 pages 272.4KB
Regulatory Filings
2020-08-30 English
New data to be presented at ESMO for eftilagimod alpha 3 pages 308.3KB
Regulatory Filings
2020-08-25 English
Appendix 4E & 2020 Full Year Statutory Accounts 85 pages 1.2MB
Annual Report
2020-08-24 English
Recruitment of stage 1 of part B in TACTI-002 study complete 2 pages 243.2KB
Regulatory Filings
2020-08-17 English
Immutep Investor Update 14 pages 1.5MB
Investor Presentation
2020-08-16 English
Lapse of Unlisted Options 1 page 232.4KB
Capital/Financing Update
2020-08-10 English
Immutep granted US patent for eftilagimod alpha 2 pages 207.3KB
Regulatory Filings
2020-08-10 English
Change in substantial holding 6 pages 2.0MB
Major Shareholding Notification
2020-07-26 English
Immutep Quarterly Activities Report & Appendix 4C 9 pages 523.1KB
Interim / Quarterly Report
2020-07-22 English
Change in substantial holding 6 pages 2.0MB
Major Shareholding Notification
2020-07-20 English
US patent granted for IMP701 antibody 2 pages 138.6KB
Regulatory Filings
2020-07-14 English
Immutep Completes Recruitment for Part A of TACTI-002 trial 3 pages 237.6KB
Capital/Financing Update
2020-06-28 English
Immutep receives A$1,437,826 R&D Tax Incentive 2 pages 231.0KB
Capital/Financing Update
2020-06-21 English
Immutep Reports First Results from INSIGHT-004 Study 3 pages 276.6KB
Interim / Quarterly Report
2020-05-31 English
Immutep announces improving data from TACTI-002 ph II trial 4 pages 308.8KB
Regulatory Filings
2020-05-31 English
Immutep receives $3.6M R&D French tax incentive 2 pages 258.9KB
Capital/Financing Update
2020-05-28 English
Immutep webcast to present new data from 2020 ASCO meeting 2 pages 272.5KB
Investor Presentation
2020-05-26 English
Change in substantial holding 6 pages 181.6KB
Major Shareholding Notification
2020-05-06 English
Immutep granted Japanese patent for eftilagimod alpha 2 pages 203.7KB
Regulatory Filings
2020-05-06 English
Cleansing Notice 1 page 190.6KB
Capital/Financing Update
2020-05-04 English
Appendix 2A 16 pages 257.4KB
Regulatory Filings
2020-05-03 English
Immutep presents at NWR Virtual Small Cap Health Conference 1
Investor Presentation
2020-04-30 English
INSIGHT-004 and TACTI-002 data to be presented at ASCO 2 pages 326.8KB
Regulatory Filings
2020-04-29 English
Immutep completes A$12 million placement 3 pages 303.5KB
Capital/Financing Update
2020-04-28 English
Immutep Investor Presentation 51 pages 2.0MB
Investor Presentation
2020-04-28 English
Proposed issue of Securities - IMM 5 pages 28.4KB
Capital/Financing Update
2020-04-28 English
Proposed issue of Securities - IMM 5 pages 31.8KB
Capital/Financing Update
2020-04-28 English
Immutep Reports Positive Phase II TACTI-002 Data 5 pages 383.2KB
Capital/Financing Update
2020-04-27 English
Trading Halt 2 pages 272.7KB
Capital/Financing Update
2020-04-26 English
Enrollment completed for the INSIGHT-004 Study 3 pages 238.5KB
Regulatory Filings
2020-04-21 English
Immutep March Quarterly Activities Report & Appendix 4C 10 pages 444.9KB
Interim / Quarterly Report
2020-04-19 English
Immutep advances its LAG-3 agonist for autoimmune diseases 2 pages 300.4KB
Capital/Financing Update
2020-04-15 English
Immutep presents TACTI-002 data at AACR Virtual Meeting 2 pages 246.8KB
Investor Presentation
2020-04-13 English
EOC Pharma confirms plans to advance Efti in China for MBC 2 pages 256.1KB
Capital/Financing Update
2020-04-07 English
Immutep AIPAC Ph2b Clinical Results & Update Webcast Slides 20 pages 943.4KB
Investor Presentation
2020-03-25 English
Immutep reports supportive efficacy data from AIPAC study 4 pages 282.1KB
Capital/Financing Update
2020-03-24 English
Immutep's Partner, EOC completes recruitment of Phase 1 3 pages 265.3KB
Capital/Financing Update
2020-03-19 English
Change of Director's Interest Notice - Mr Chamberlain 2 pages 189.4KB
Director's Dealing
2020-03-15 English
Immutep receives 2nd IND approval for efti from US FDA 2 pages 254.9KB
Regulatory Filings
2020-03-08 English
Change in substantial holding 6 pages 256.3KB
Regulatory Filings
2020-03-01 English
Immutep Clinical Update & Results Global Webcast Slides 23 pages 1.1MB
Investor Presentation
2020-02-24 English
Half Yearly Report and Accounts 30 pages 796.4KB
Interim / Quarterly Report
2020-02-20 English
Change in substantial holding 6 pages 252.8KB
Regulatory Filings
2020-02-20 English
Immutep reports positive TACTI-002 data 5 pages 367.9KB
Regulatory Filings
2020-02-18 English
Change in substantial holding 6 pages 236.6KB
Regulatory Filings
2020-02-04 English
Immutep to present TACTI-002 data at German Cancer Congress 2 pages 272.4KB
Regulatory Filings
2020-02-03 English
Appendix 4C - quarterly 5 pages 191.2KB
Interim / Quarterly Report
2020-01-28 English
Immutep Activities Report 4 pages 241.6KB
Interim / Quarterly Report
2020-01-28 English
Immutep Corporate Presentation 33 pages 1.5MB
Investor Presentation
2020-01-09 English
Immutep expands Part C of TACTI-002 due to positive data 2 pages 254.4KB
Capital/Financing Update
2020-01-08 English
Change in substantial holding 6 pages 264.8KB
Regulatory Filings
2020-01-05 English
Appendix 3B 15 pages 515.3KB
Share Issue/Capital Change
2020-01-01 English
Change of Director's Interest Notice 3 pages 185.6KB
Director's Dealing
2020-01-01 English